Humatica announces expansion plans for Asia business

ndetails

Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to announce the appointment of Jen Jee Chan as Managing Partner Asia to drive growth and expansion from Singapore

Despite a challenging market environment during the global pandemic, Humatica finished 2021 with 19% growth and record fee revenues. Based on being named as one of the most exciting 100 private firms by RedHerring for its innovative services, Humatica is uniquely poised to expand in Asia’s high growth private equity markets.

The appointment of Jen Jee Chan, based out of Singapore, is a logical extension of a two year partnership with DotProjects serving leading private equity funds in Asia, and takes this successful collaboration to the next level.

As the Managing Partner Asia, Jen Jee will assume responsibility for driving the growth of the business in key Asian markets, ensuring consistent quality in project delivery and focused attention to meet Humatica’s private equity client’s needs and high expectations.

Jen Jee brings over 20 years of management and consulting experience. He is a proven entrepreneurial leader with deep knowledge in org transformation, sustainability and Environment Social Governance (ESG). He is uniquely experienced to serve the evolving needs of private equity sponsors and accelerate Humatica’s growth in Asia.

According to Andros Payne, Managing Partner of Humatica:

“We are delighted to welcome Jen Jee to our growing team. Our collaboration with him over the past few years has confirmed our respect for his competence and ethics as a trusted advisor to our private equity clients and their entrepreneurial management teams.”

Jen Jee Chan, adds:

“I am indeed excited to embark on this journey with Andros and Humatica. I look forward to the opportunity to work closely with our partners and clients to co-create value towards a sustainability-driven organisational excellence outcome for portfolio companies.”

To download the news release in PDF format, klicken Sie hier.

Related News

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards
27 Jan., 2026 By Humatica

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards

Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…

Read more arrowicon
Humatica is again finalist for prestigious Real Deals Award
16 Jan., 2026 By Humatica

Humatica is again finalist for prestigious Real Deals Award

Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…

Read more arrowicon
Humatica is a Great Place to Work™ – we are officially accredited once again!
06 Jan., 2026 By Humatica

Humatica is a Great Place to Work™ – we are officially accredited once again!

London, January 2026 – Humatica, an award winning leader in organizational transformation for Private Equity, has been officially accredited as a Great Place to Work…

Read more arrowicon